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The SOX10 transcription factor is a characteristic marker for migratory multipotent neural crest (NC)
progenitors as well as several of their differentiated derivatives. The involvement of SOX10 in
Waardenburg–Hirschsprung disease (pigmentation defects, deafness and intestinal aganglionosis)
and studies of mutant animal models have contributed signiﬁcantly to the understanding of its
function in neural crest cells (NCC) in general and in the melanocytes and enteric nervous system
(ENS) in particular. Cell-based studies have further demonstrated the important roles of this
transcription factor in maintaining the NC progenitor cell number and in determining glial cell
fate. Phenotypic variability observed among patients presenting with SOX10 mutations is in
agreement with molecular genetics and animal model studies, which revealed that SOX10
cooperates with different partner factors; a number of genetic modiﬁers of SOX10 have been
identiﬁed. This study reviews the expression, regulation, and function of SOX10 in normal
development of the ENS and in disease conditions, as well as the genetic and molecular interac-
tions of SOX10 with other ENS genes/factors. We also discuss future research areas. Further
understanding of SOX10 function will beneﬁt from genomic and cell biological studies that integrate
the cell-intrinsic molecular mechanisms and the interactions of the enteric NCC with the niche
environment.
& 2013 Elsevier Inc. All rights reserved.Introduction
SOX10 belongs to the SOX family of transcription factors, whose
members are deﬁned based on the presence of a 79 amino-acid DNA-
binding domain with strong amino acid similarity (usually >50%) to
the HMG box of SRY (hence SOX, Sry bOX) (Bowles et al., 2000;
Schepers et al., 2002; Wegner, 1999). The SOX factors are involved in
many developmental processes, such as male differentiation, skele-
togenesis, neurogenesis, and neural crest (NC) development, where
they control stemness, cell fate and differentiation (for reviews see for
examples Akiyama and Lefebvre (2011), Guth and Wegner (2008),
Haldin and LaBonne (2010), Jakob and Lovell-Badge (2011),
Kashimada and Koopman (2010), Lefebvre et al. (2007), Uchikawa
et al. (2011), Wegner (1999, 2009)).ll rights reserved.
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. Bondurand),In the past 15 years, SOX10 has moved into the spotlight.
Research examining its role in NC derivatives formation and in
oligodendrocytes development has expanded rapidly (for reviews
see Hong and Saint-Jeannet (2005), Kelsh (2006), Mollaaghababa
and Pavan (2003), Stolt and Wegner (2009), Wegner (2005),
Wegner and Stolt (2005)). In this review, we describe the role of
this transcription factor during enteric nervous system (ENS)
development, gathering genetic, molecular and developmental
data related to SOX10 structure, expression, function, regulation
and interaction with other key ENS players. We also summarise
records related to SOX10 involvement in human genetic disorders
associated with Hirschsprung disease, the main genetic cause of
functional intestinal obstruction with an incidence of 1/5000 live
births (Amiel et al., 2008; Goldstein et al., 2013; Obermayr et al.,
2012) and discuss future research areas.The dominant megacolon (Dom) mouse and identiﬁcation Ćof
the Sox10 gene
Lane and Liu (1984) reported the appearance of a new domi-
nant spotting mutation that produces megacolon, which they
called dominant megacolon (Dom). The semi-dominant mutation
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background in the Mouse Mutant Stock Center of the Jackson
Laboratory. The ﬁrst crosses suggested that homozygotes die in
utero prior to 13 days of gestation; 30% of the heterozygotes die
before weaning. Life spans of the heterozygous mice ranged from
2 days to over 12 months and mutant mice could be recognised by
the presence of a white belly spot, white feet, and, in some
animals, a markedly distended colon. Histopathology revealed
the absence of ganglion cells in the distal half of the colon, a
defect that characterises Hirschsprung disease (HSCR, intestinal
aganglionosis) in human. An overall reduction in the number of
mucin-producing cells and an almost total absence of enterochro-
mafﬁn cells were also observed (Lane and Liu, 1984).
Genetic studies revealed that the Dom mutation is located on
the mid-region of chromosome 15 (Lane and Liu, 1984). The Dom
locus was then genetically mapped with high resolution using
several intra- and inter-speciﬁc mouse crosses and speciﬁc DNA
microsatellites, and the homology between the Dom locus and
human chromosome 22q12-q13 was established (Pingault et al.,
1997; Puliti et al., 1995; Southard-Smith et al., 1999b). Positional
cloning and sequencing of various candidate genes were per-
formed, and revealed that Sox10 is the causative gene in the
Dom mutant (Herbarth et al., 1998; Southard-Smith et al., 1998).
First cloned as a glial cell transcription factor (Kuhlbrodt et al.,
1998), Sox10 was subsequently revealed as a major player in the
development of NC cells (NCC) and the ENS, in particular (for
reviews see Heanue and Pachnis (2007), Kelsh (2006),
Mollaaghababa and Pavan (2003), Pingault et al. (2010), Wegner
(1999, 2005, 2009)).Gene structure and protein domains
The human SOX10 and mouse Sox10 genes encode an open
reading frame of 466 amino acids that display 92% DNA and 98%
amino-acid sequence identities (Herbarth et al., 1998; Pingault et al.,
1998; Pusch et al., 1998). In the absence of a complete description of
the human gene 5′-UTR non-coding exon(s), the most commonly
exon numbering system used is: non-coding exons 1 and 2, ATG
codon in exon 3 and stop codon in exon 5 ((Pingault et al., 1998);
Fig. 1A) No typical TATA box-like sequence has been identiﬁed, but
two functional polyadenylation signals are present in the 3′-UTRFig. 1. Structure of the SOX10 gene and protein. (A) Schematic view of the human SO
exonic non-coding regions (blue), and intronic regions (grey) are highlighted. Putative
polyadenylation signals is shown. Scale¼500 bp. (B) Structure of human SOX10 protein w
K2 domain; TA, transactivation domain. Numbers refer to amino-acid residues. Black arro
HMG domain represent the NLS sequences, one at each end of the HMG domain, and t(Fig. 1A; (Pusch et al., 1998)). A major transcript of ∼3 kb was detected
by northern blot analysis (Bondurand et al., 1998; Herbarth et al.,
1998; Pusch et al., 1998; Southard-Smith et al., 1999a) and is
consistent with the predicted SOX10 mRNA sequence.
Several protein domains crucial for SOX10 functions have been
characterised (Fig. 1B; (for reviews see Barrionuevo and Scherer
(2009), Wegner (1999, 2009))). These include the DNA-binding
HMG domain (amino acids 101−180) and a strong transactivation
domain at the extreme C-terminus (amino acids 400−466). These
domains are highly similar to the corresponding regions in SOX8
and SOX9, to which SOX10 is closely related and with which it
forms the SOX-E subgroup (Barrionuevo and Scherer, 2009;
Schepers et al., 2002; Wegner, 1999). The HMG domain forms
an L-shaped module composed of three helices that binds to
DNA in the minor groove. This motif also functions in intracel-
lular transport regulation and interacts with partner proteins
(for examples see Kamachi et al. (2000), Malki et al. (2010),
Wegner (1999), Wilson and Koopman (2002), Wissmuller et al.
(2006)). Like other SOX proteins, SOX10 also contains two
nuclear localisation signals (NLSs), one at each end of the
HMG domain (Fig. 1B, for reviews see Barrionuevo and Scherer
(2009), Malki et al. (2010)). A nuclear export signal (NES) in the
centre of the HMG domain has been described (Rehberg et al.,
2002). Shuttling in and out of the nucleus seems crucial for
SOX10-mediated transactivation. While nucleocytoplasmic
shuttling of several SOX factors during development is well
documented (Malki et al., 2010; Smith and Koopman, 2004),
in vivo regulation of SOX10 through nuclear translocation
remains to be studied.
Two other regions conserved among SOX-E proteins include
amino acids 61−101 and 233−306 (Fig. 1B). The ﬁrst region is a
DNA-dependent dimerisation domain required for cooperative
binding of two SOX10 proteins on target genes (Peirano and
Wegner, 2000). The second domain, called the E-region or K2
domain, functions as a strong transcription activation domain in
SOX8, but not in SOX9 (Barrionuevo and Scherer, 2009; Schepers
et al., 2000). Deletion of this domain from SOX10 revealed its
function as a weak context-dependent transactivation domain
during mouse development (Schreiner et al., 2007). Recently, this
domain was shown to mediate interactions with AP2α, suggesting
that it could also be important for protein–protein interactions and
co-factor activity (Wahlbuhl et al., 2011).X10 gene. Start and stop codons are indicated. Exonic coding regions (dark blue),
exon 1 is indicated with a question mark and the sequence surrounding the two
ith functional domains. Dim, dimerisation domain; HMG, high-mobility group; K2,
wheads represent localisation of junctions between exons. The blue lines above the
he purple line the NES sequence.
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Sox10 is expressed in all NCC as they delaminate from the
neural tube, and is therefore commonly used as an NC marker.
During mouse embryo development, Sox10 is ﬁrst detected in the
anterior neural folds at E8.5. By E9, Sox10 is notably expressed in
migrating NCC of the vagal, truncal and sacral origins “en route” to
their ﬁnal destination (Aoki et al., 2003; Bondurand et al., 1998;
Britsch et al., 2001; Dutton et al., 2001; Honore et al., 2003;
Kuhlbrodt et al., 1998; Pusch et al., 1998; Southard-Smith et al.,
1998). In the developing gut, Sox10 is found in all the ENS
progenitors that migrate in a rostro-caudal direction to colonise
the foregut, midgut and hindgut and form the ganglionic plexus of
the ENS (Bondurand et al., 1998, 2003; Kuhlbrodt et al., 1998;
Paratore et al., 2002; Southard-Smith et al., 1998; Young et al.,
2004, 2003). Sox10 is also widely expressed in the developing
peripheral nervous system (PNS), including cranial ganglia, dorsal
root and sympathetic ganglia, and in other NC derivatives such as
melanoblasts (see for examples Bondurand et al. (1998), Britsch
et al. (2001), Cheng et al. (2000), Dutton et al. (2001), Kuhlbrodt
et al. (1998), Pusch et al. (1998)) and for reviews Guth and Wegner
(2008), Hong and Saint-Jeannet (2005), Mollaaghababa and Pavan
(2003), Wegner (2005)). As the NCC differentiate, Sox10 expression
is maintained in melanoblasts (Sox10 is expressed in melanocytes
in the epidermis and hair follicles at later stages) and glial
lineages, including enteric glia and glia in the PNS, but down-
regulated in cells that are committed to the neuronal lineages (see
for example Aoki et al. (2003), Britsch et al. (2001), Deal et al.
(2006),; Kim et al. (2003), Potterf et al. (2001), Sonnenberg-
Riethmacher et al. (2001), Wegner (2005), Young et al. (2004,
2003)). By E14.5, many glandular NC-derived tissues including
salivary and lacrimal glands also express Sox10 (Deal et al., 2006).
Most signiﬁcantly, in addition to these NC derivatives, Sox10 is
expressed in the placode-derived otic vesicle from E9.5 onward,
and in oligodendrocytes throughout their development (Breuskin
et al., 2009, 2010; Stolt et al., 2002; Stolt and Wegner, 2009;
Watanabe et al., 2000). The expression proﬁle of Sox10 correlates
very well with the spectrum of phenotypes in patients with SOX10
mutations, who suffer from colonic aganglionosis, pigmentation
defects, deafness, and other defects, including demyelination ofFig. 2. SOX10 animal models. (A) Representative images of the Sox10lacZ knock-out mo
X-Gal staining of E11.5 heterozygous embryo shows lacZ reporter gene expression in
Sox10NGFP. GFP expression at E11.5 recapitulates endogenous Sox10 expression patte
(C) Zebraﬁsh cls mutant. Wild-type and sox10 mutant embryos at 5 days post-ferti
immunoﬂuorescence reveals severe peripheral neuron defects, with enteric neurons (arr
Modiﬁed from (Carney et al., 2006).the peripheral and central nervous systems (see for examples
(Inoue et al., 2004; Pingault et al., 1998, 2010)).
The Dom mouse study ﬁrst shed light on the essential function
of this transcription factor in the enteric and melanoblast lineages
(Herbarth et al., 1998; Kapur, 1999; Lane and Liu, 1984; Southard-
Smith et al., 1998). The Dom mutation is an insertion of a guanine
after position 579. This frameshift mutation leaves the ﬁrst 193
amino acids of SOX10 including the HMG domain, but replaces the
normal C-terminal half with 99 unrelated amino acids (Herbarth
et al., 1998; Southard-Smith et al., 1998). The resulting protein is
detected by immunohistochemistry, arguing against protein
degradation or instability (Kim et al., 2003). Despite the unaltered
HMG domain sequence, the mutant protein lost its capacity to
bind to some, but not all, tested target sequences in vitro (Cossais
et al., 2010; Herbarth et al., 1998). In addition, the transactivation
capacity and synergistic action with several co-factors are altered
(Bondurand et al., 2000; Cossais et al., 2010; Herbarth et al., 1998).
A knockout model, Sox10tm1Weg (Britsch et al., 2001), often
referred as Sox10lacZ; (Fig. 2A), was also generated and present
with phenotypes similar to the Dom mutant.
While Sox10 is widely expressed in NCC, it is not required for
NC formation. In homozygous Sox10Dom and Sox10lacZ mutants
embryos, NC-derived cells and structures are present, although
reduced. In contrast, both the spontaneous Sox10Dom mutant and
mice carrying the targeted Sox10lacZ mutation display various NC
defects later during development ((Britsch et al., 2001; Herbarth
et al., 1998; Kapur, 1999; Southard-Smith et al., 1998) and for
reviews see for examples Kelsh (2006), Mollaaghababa and Pavan
(2003), Wegner (1999, 2009)). Sox10 heterozygotes present with
pigmentation defects and distal enteric aganglionosis, in particular
(Fig. 2A). Phenotypes of Sox10Dom/+ and Sox10lacZ/+ mice were
compared on identical genetic backgrounds (Cantrell et al., 2004;
Cossais et al., 2010; Southard-Smith et al., 1999a). Separate studies
show that Sox10Dom/+ embryos exhibit increased penetrance and
severity of aganglionosis compared to Sox10lacZ/+, arguing that the
effect of the Dom mutation on ENS development is not simply the
result of Sox10 inactivation and haploinsufﬁciency ((Cantrell et al.,
2004; Cossais et al., 2010). Interestingly, the TA deleted form of
SOX10 shows dominant negative properties in vitro (Potterf et al.,
2000). However, very few differences in phenotype were observeduse model. First picture shows heterozygotes pigmentation defects. Whole-mount
various NC derivatives including ENCC along the foregut. (B) GFP-knock-in model
rns. The two pictures represent E11.5 heterozygote and homozygote embryos.
lisation (dpf). Melanocytes ((n)) are visible in WT, but not in mutants. Anti-Hu
ow) missing and sensory neurons (arrowheads) severely reduced in sox10 mutants.
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negative function of the Dom mutation (Cossais et al., 2010).
On the other hand, homozygous animals invariably present
with a complete absence of enteric neurons and glia and their
precursors along the entire length of the oesophagus and gastro-
intestinal tract (Kapur, 1999). Marked deﬁciencies in several other
NC derivatives, including sensory and autonomic ganglia in the
PNS, were observed. NC-derived cranial ganglia (V dorsomial, IX
superior and X superior) are absent, whereas those derived from
ectodermal placodes are preserved, and adrenal chromafﬁn cells
are absent (Herbarth et al., 1998; Kapur, 1999; Southard-Smith
et al., 1998). Rostral hypoplasia and caudal absence of sympathetic
ganglia and dorsal root ganglia were reported (Kapur, 1999;
Sonnenberg-Riethmacher et al., 2001). No embryos survived to a
stage where coat pigmentation could be assessed, but at E11.5
homozygous embryos entirely lack neural crest-derived cells
expressing the lineage markers KIT, MITF, or DCT. Moreover, neural
crest cell cultures derived from homozygous embryos do not give
rise to pigmented cells (Potterf et al., 2001; Southard-Smith et al.,
1998). Depending on the genetic backgrounds, between 50% to
almost all homozygous embryos die between E12 and E13; the
remainder die between E18 and P1 (Kapur, 1999). Lung or heart
defects are proposed to explain the lethality but the underlying
mechanism remains to be determined.
More recently, a conditional knock-out, a Sox10-Histone2BVenus
transgenic mice and a GFP-knock in model Sox10NGFP were generated
(Corpening et al., 2011; Finzsch et al., 2010; Zhang et al., in prepara-
tion). GFP expression recapitulates endogenous Sox10 expression
patterns ((Corpening et al., 2011; Finzsch et al., 2010) and Fig. 2B),
providing new valuable models for in vitro and in vivo cell fate
analyses.
Finally, various zebraﬁsh mutant lines were identiﬁed in
mutagenesis screens (Kelsh et al., 1996; Kelsh and Eisen, 2000;
Malicki et al., 1996). Several Sox10 mutations were characterised
and rescue of the colourless (cls) phenotype by sox10 was demon-
strated (Carney et al., 2006; Dutton et al., 2001). In cls mutants,
premigratory NCCs are unaltered but mutants present with mel-
anocytes, enteric and PNS defects. cls mutants present with only
∼13% of the enteric neurons (Hu and cRet positive cells) relative to
wild-type along the entire length of the gut; enteric glial cells are
highly reduced or absent ((Dutton et al., 2001; Elworthy et al.,
2005; Kelsh and Eisen, 2000); Fig. 2C).SOX10 function: maintenance factor for NC stem cells and glial
cell determinant
As stated above, while Sox10/SOX10 is widely expressed in NCC,
it does not seem to be required for NC formation. Indeed, at E8.5,
generation and emigration of NCC were unaltered in the homo-
zygous mutants (Britsch et al., 2001; Kapur, 1999). On the same
line, NCC can be isolated from the dorsal root ganglia of homo-
zygous Sox10lacZ embryos at E13, indicating that NC induction,
speciﬁcation and formation are not affected in the absence of
Sox10 (Paratore et al., 2001). Interestingly, overexpression of Sox9
in chick neural tube, and in Xenopus, led to an expansion of NCC
domain. Similarly, overexpression of Sox8 or Sox10 can also induce
an NCC-like fate, although Sox10 is not as effective as Sox9 (Aoki
et al., 2003; Cheung and Briscoe, 2003; Cossais et al., 2010;
McKeown et al., 2005). Overexpression of Sox9 upregulates Sox10
and this could result in an additive effect in overexpression
experiments (Cheung and Briscoe, 2003). Thus, while Sox10 is
not essential for NC formation in vivo, forced expression of this
transcription factor in neural tissue can impose NCC-like
characteristics.Insights into the cellular functions of Sox10 at later stages of
NCC development have been obtained through several mutant
animal models studies. In mice, heterozygous Sox10lacZ/+ enteric
NCC (ENCC) survive as well as wild-type cells, but they progres-
sively lose their progenitor state and become committed to the
enteric neuroblast lineage (Paratore et al., 2002). By contrast, both
homozygous Sox10Dom/Dom and Sox10lacZ/lacZ vagal NCC exhibit
extensive cell death prior to gut colonisation, a defect most
probably at the origin of the total absence of ENS observed in
these mutants (Kapur, 1999; Southard-Smith et al., 1998). Cell
death is also increased in undifferentiated post-migratory trunk
NCC that lack Sox10, suggesting a role of this transcription factor in
the survival of multipotent NCC (Paratore et al., 2001; Sonnenberg-
Riethmacher et al., 2001). Increased cell apotosis was also
observed in zebraﬁsh and Xenopus upon Sox10 ablation (Dutton
et al., 2001; Honore et al., 2003). Although Sox10 is implicated as a
survival factor, the combination of programmed cell death and
undifferentiated cells raises the possibility that apoptosis may be a
secondary consequence of the failure in NCC self-renewal and
lineage commitment (Dutton et al., 2001).
The in vivo function of Sox10 in the maintenance of ENC
progenitor cells is further supported by neural crest stem cell
(NCSC) culture experiments. NCC, as a migratory and pluripotent
cell population, display stem cell properties (for reviews see
Bronner and Le Douarin (2012), Le Douarin and Kalcheim
(1999)). Clonogenic cultures have been successfully established
of NCSC obtained from different sources, including embryonic gut
and sciatic nerve (rat E14), as well as adult gut (for review see
Heanue and Pachnis (2007), Hotta et al. (2011)). There are cell-
intrinsic differences among cells isolated from different locations:
NCSC from embryonic gut are more neurogenic, while those from
embryonic sciatic nerve are more gliogenic, in transplantation
assays (Bixby et al., 2002; Bondurand et al., 2003; Mosher et al.,
2007). Using a gain-of-function approach (E10.5 trunk rat NCSC
infected with a retroviral construct allowing constitutively expres-
sion of mouse Sox10), SOX10 was shown to maintain the multi-
potency of NCSC by inhibiting Neuregulin-1, BMP2/4 or TGFβ-
induced differentiation (Kim et al., 2003). A similar study using
mouse ENC progenitor cells also demonstrated that overexpres-
sion of SOX10 inhibited enteric neuron and glia differentiation
without altering commitment to the neurogenic lineage, thereby
maintaining both the neurogenic and gliogenic potential of the
ENC progenitor cells (Bondurand et al., 2006). A signiﬁcant
reduction in the size of neurospheres and in the number of enteric
progenitor cells obtained from E11.5 Sox10 heterozygous gut
cultures were also observed (Bondurand et al., 2006). As formation
of neurospheres and recovery of progenitors from dissociated gut
cultures depends on the self-renewing capacities of undifferen-
tiated ENC progenitors (Bondurand et al., 2003), these results
suggest that Sox10 levels are also critical for the maintenance of
the ENS progenitor pool. On the same line, when ﬂow cytometry
was used to isolate live enteric progenitors by the P75 and HNK1
markers, frequency of enteric progenitors isolation was severely
reduced in Sox10Dom/+ embryos relative to wild-types (Walters
et al., 2010). Despite this reduction, the proportion of multipotent
colonies was similar. No effect on enteric progenitor proliferation
was observed, but developmental potential was substantially
shifted with an increased proportion of neurons (Walters et al.,
2010). Altogether, these data suggest that SOX10 normally main-
tains ENCC multipotency, but the molecular underlying mechan-
isms still need to be clariﬁed.
In addition to maintenance of multipotency, SOX10 is also
required for glial fate acquisition. In the Sox10Dom/Dom and Sox10-
lacZ/lacZ mutants, the glial cell marker B-FABP/BLBP was never
detected in the dorsal root ganglia, indicating that gliogenesis is
completely blocked. Homozygous Sox10lacZ/lacZ mutants lack all
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NCCs to acquire a glial cell fate (Britsch et al., 2001; Wegner, 2009;
Wegner and Stolt, 2005). The requirement for Sox10 in gliogenesis
is further demonstrated by in vitro culture of NCCs isolated from
dorsal root ganglia of E9 Sox10lacZ/lacZ embryos (Paratore et al.,
2001). Under culture conditions that promote O4-positive
Schwann cell differentiation, surviving homozygous Sox10lacZ/lacZ
cells fail to differentiate into any glial cells, but generate P75 and
NF160 negative cells that showed non-neural morphology and
often expressed smooth muscle actin. Sox10lacZ/+ cells also show
altered glial fate. When Sox10lacZ/+ mutant NCC are plated at clonal
density, gliogenesis remains drastically reduced even in the pre-
sence of the glia inducing factor Neuregulin-1 (Paratore et al.,
2001). More recently, the use of a conditional mutant allele
demonstrated that Sox10 is also required for the later stages during
Schwann cell development (Finzsch et al., 2010). In general, accu-
mulating evidence indicates that Sox10 is required in multiple steps
of glial cell speciﬁcation, differentiation and maintenance in the PNS,
as well as in oligodendroglial development in the CNS (Bremer et al.,
2011; Stolt et al., 2002; Stolt and Wegner, 2009; Wegner, 2009;
Wegner and Stolt, 2005). Whether Sox10 is required for gliogenesis in
the ENS will require further investigations.
Finally, the observed defects have been described as cell
autonomous. However, the existing data do not exclude the
possibility that some of the defects observed in Sox10 mutants
could be mediated by modiﬁcation of local environmental cues
(Kapur et al., 1996) and one role of SOX10 may be to regulate
production of intercellular signals. The effect of SOX10 on the
microenvironment early during NC migration and later within the
gut remains to be determined. However, recent data suggest that
SOX10 might play a role in cell adhesion and affect extracellular
matrix components (ECM), including integrins and L1-cam, lead-
ing to altered cell migration and cell adhesion capacities (Wallace
et al., 2010; Watanabe et al., 2013).Fig. 3. Co-expression of Sox10 and Sox2 in the developing enteric nervous
system. (A) Immunohistochemical analysis of E14.5 mouse embryo sections
showing overlapping expression of Sox10 (green) and Sox2 (red) in ENCC in the
midgut. (B) Immunohistochemical analysis showing Sox2 expression during
differentiation processes. Sox2 (green) co-localises with the glial marker BLBP
(red), but not the neuronal marker PGP9.5 (red).Functional redundancy among Sox genes
Considering that SOX8, SOX9 and SOX10 recognise the same
DNA sequence, possess conserved functional domains, and have
overlapping expression proﬁles in the NCC, expression of Sox8 or
Sox9 is often proposed to compensate for Sox10 loss of function
(for reviews see for example Barrionuevo and Scherer (2009),
Haldin and LaBonne (2010), Hong and Saint-Jeannet (2005), Stolt
and Wegner (2009), Taylor and Labonne (2005)). The three
members of the SOX-E subgroup are indeed co-expressed in NC
progenitors with subtle differences in their onset and maintenance
of expression across different species. In both chick and mouse
embryos, upon NC induction, Sox9 is expressed in the premigra-
tory NCC together with FoxD3 and Slug; Sox9 is then down-
regulated in emigrating NCC. Sox10 is switched on immediately
after Sox9 (Cheung and Briscoe, 2003). Sox8 is also expressed in
NCC soon after Sox9, and Sox8 expression overlaps with Sox10 (Bell
et al., 2000). In Xenopus, Sox8 is the ﬁrst Sox-E gene expressed in
NC progenitors, followed immediately by Sox9, but Sox10 is not
expressed until the late neural stage (Aoki et al., 2003; Honore
et al., 2003). In zebraﬁsh, Sox8 is not expressed at all and the two
orthologs of Sox9 are differentially expressed (Chiang et al., 2001).
Sox9b is ﬁrst expressed in NC progenitors as early as FoxD3, while
Sox9a and Sox10 are detected later, upon neurulation. Following
the initial expression in the delaminating NCC, Sox9 is switched off
but Sox10 expression is sustained in the migrating NCC, including
both the medial and dorsolateral migratory streams in the trunk
(Cheung and Briscoe, 2003). The absence of early NC defects in
Sox10 mutants is therefore probably due to compensation by other
SOX-E members, Sox9 in particular.Sox10 and Sox8 are also co-expressed in the vagal NCC entering
the gut, enteric NCC (ENCC) along the gut and in the glial cells
(Maka et al., 2005). Sox8lacZ mutant mice do not show any signs of
megacolon or pigmentation defects (Sock et al., 2001). In Sox8lacZ/+
and Sox10lacZ/+ double heterozygotes, however, the loss of Sox8
increases both the penetrance and severity of the phenotype
observed, as the double mutants exhibited higher mortality and
extended aganglionosis (Maka et al., 2005). Defects in oligoden-
drocyte differentiation caused by Sox10 are also worsened by loss
of Sox8 (Stolt et al., 2004). A gene replacement study has shed light
on the extent of functional equivalence between Sox8 and Sox10
in vivo. When endogenous Sox10 expression is replaced by Sox8,
the PNS appears normal whereas defects in the ENS and in
oligodendrocyte development are only partially rescued. Sox8
expression failed to rescue the phenotype in the melanocytes
lineage (Kellerer et al., 2006). The extent of functional equivalence
therefore depends on the tissue and suggests that both genes have
more unique functions than previously appreciated.
In addition to Sox8 and Sox10, Sox2, a member of the SoxB1
subgroup, is also expressed in the developing mouse ENS (Heanue
and Pachnis, 2006, 2011). From E10.5, Sox2 is expressed in the
ENCC in the gut, and its expression overlaps with Sox10 in the ENC
progenitors (Fig. 3A). During subsequent development, Sox2 and
Sox10 are co-localised in the ENCC as well as in the differentiated
glial cells (Fig. 3B). Sox2 and Sox10 may have cooperative or
redundant functions in the ENS. Further studies using inducible
tissue-speciﬁc genetic manipulations will be necessary to deline-
ate the speciﬁc functions and interactions among Sox2, Sox8 and
Sox10.
Finally, interplay between Sox10 and Sox5 is also observed
during melanocytes development (Stolt et al., 2008). Loss of Sox5
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mutants. SOX5 binds to the regulatory regions of melanocytic
SOX10 target genes and recruits CtBP2 and HDAC1, resulting in
direct inhibition of SOX10-dependent promoter activation (Stolt
et al., 2008). Whether such modulatory mechanisms occur during
ENS development remains to be determined.SOX10 target genes in the enteric nervous system
The identiﬁcation of SOX10 target genes has helped elucidate
the function and mechanism of action of this transcription factor
during development. All SOX proteins bind to the minor groove of
DNA and recognise the common consensus motif 5′ (A/T)(A/T)CAA
(A/T)G-3′. This binding causes DNA bending, which has led to the
assumption that SOX proteins may function as architectural
proteins (Wegner, 1999). To direct gene expression, SOX factors
combine with different protein partners (Kamachi et al., 2000;
Wilson and Koopman, 2002). Interestingly, several SOX proteins,
SOX10 included, change partners during development. Their
speciﬁcity/selectivity is therefore context-dependent and relies,
among other things, on the arrangement of SOX and partner
factors binding sites and ﬂanking sequences. Mediated through
their DNA-dependent dimerisation domain, SOX-E proteins can
also recognise particular arrangements of two adjacent SOX
binding sites (Peirano and Wegner, 2000; Wegner, 2009).
A plethora of SOX10 target genes has been identiﬁed. These
include numerous genes essential for Schwann cell and/or oligo-
dendrocyte development, such as EGR2, MPZ (P0), MBP, PMP22,
MAG, OCT6, GJB1 (Cx32), GJC2 (Cx47), CNTF, Sh3kbp1, ErbB3, PLP,
SOD3, DHH, CHRNB4 and CHRNA9, as well as various genes
involved in melanocytes development, such as MITF, Trp2/Dct,
Tyrosinase/Tyrp1, MEF2C, and Sox10 itself (Agarwal et al., 2011;
Bondurand et al., 2001, 2000Ghislain and Charnay, 2006;
Hodonsky et al., 2012; Ito et al., 2006; Jagalur et al., 2011; Jang
and Svaren, 2009; John et al., 2011; Jones et al., 2007; Kuspert
et al., 2012; Lee et al., 2008, 2000; Liu et al., 1999; Ludwig et al.,
2004; Melnikova et al., 2000; Murisier et al., 2007; Peirano et al.,
2000; Potterf et al., 2000; Prasad et al., 2011; Schlierf et al., 2006;
Scoﬁeld et al., 2008; Valor et al., 2003; Verastegui et al., 2000).
Several monomeric and/or dimeric SOX binding sites have been
identiﬁed in the regulatory regions of these genes. These sites do
not always match the already loosely deﬁned core consensus. In
dimeric arrangements, for example, one or both binding sites
further deviate at one or two positions from the core consensus
and are weak monomeric sites. It has been suggested that dimeric
sites pointing towards each other and with speciﬁc inter-site
spacing could be a hallmark for SOX-E responsive regions and
could be useful for SOX10 target gene prediction (Antonellis et al.,
2008). However, some of the above examples clearly show that
monomeric sites can be sufﬁcient for SOX10 dependent activity
(see for examples (Bondurand et al., 2000; Wahlbuhl et al., 2011)).
Many co-factors have been identiﬁed or proposed, including
PAX3, MITF, SP1, EGR2, OCT6, Nmi, AP2α, FoxD3, and SOX2 (for
examples see Agarwal et al. (2011), Bondurand et al. (2001, 2000),
Jang and Svaren (2009); Jones et al. (2007); Ludwig et al. (2004);
Schlierf et al. (2005); Wahlbuhl et al. (2011); Wei et al. (2004)). In
some cases, cooperative activity depends solely on SOX10 binding
to the DNA and recruiting co-factor (as in the case of FoxD3 on the
Sox10 enhancer); in some cases, binding of both factors to target
gene regulatory sequences is required (as in the case of PAX3 on
the MITF regulatory elements); in other cases, co-factor binding is
sufﬁcient to recruit SOX10 (as in the case of RET and EDNRB
activation, see below). Here, we focus on target genes identiﬁed
during ENS development (Fig. 4).The RET tyrosine kinase receptor gene was the ﬁrst SOX10
target identiﬁed ((Lang et al., 2000); Fig. 4A and B). Although
genome wide studies failed to detect genetic interactions between
Sox10 and Ret both in mouse and human (de Pontual et al., 2007;
Owens et al., 2005), analysis of the 5′ region of Ret led to the
characterisation of a 750 bp region located about 3.5 kb upstream
of the transcription start site that, when linked to the minimal
promoter, is activated by PAX3 and SOX10 (Fig. 4B, SP enhancer;
(Lang et al., 2000)). A core sequence of 45 bp containing a SOX10
binding site followed by a PAX3 binding site 12 bp downstream
was identiﬁed at the 3′ end of this region. The SOX binding site is
far from perfect (see sequence in red, Fig. 4B), but an electro-
phoretic mobility shift assay (EMSA) conﬁrmed binding (Lang
et al., 2000; Lang and Epstein, 2003). Synergistic activation of
the Ret enhancer requires a direct interaction that is mediated by
the paired domain of PAX3 and the HMG domain of SOX10. SOX10
binding is not a prerequisite for synergistic activity; when bound
to DNA, PAX3 is able to recruit SOX10 and cause enhanced
transcriptional activation. This observation explains why some
SOX10 mutants that cannot bind DNA retain the ability to activate
the Ret enhancer in the presence of PAX3 (Lang and Epstein, 2003).
Phox2b and Nkx2.1 also activate this RET enhancer, and coordinate
action between Nkx2.1 and SOX10 is reported (Leon et al., 2009).
More recently, human association studies, followed by in vitro
analysis of identiﬁed SNPs, as well as extensive analysis of regions
covering 220 kb encompassing the RET locus, led to the identiﬁca-
tion of another SOX10 regulated region located in the ﬁrst intron
of RET, called MSC+9.7 (Fig. 4B; (Emison et al., 2010, 2005; Grice
et al., 2005)). Two putative SOX10 binding sites are present within
the region. The ﬁrst one matches the consensus core binding
sequence, but the second (called BS2, see Fig. 4B) does not.
Deletion of the ﬁrst binding site did not affect reporter gene
expression in vitro, but deletion of the second site resulted in
drastic reporter gene downregulation, thus validating its func-
tional relevance (Emison et al., 2010). A relatively common HSCR
susceptibility variant has been identiﬁed within this second site.
The associated T allele reduces in vitro enhancer activity compared
to the wild-type allele (Emison et al., 2005). RET is therefore under
the regulation of at least two distinct regions controlled by SOX10.
The presence of multiple SOX binding sites suggest that SOX10
binding may alter local chromatin structure at speciﬁc sites and
allow the interaction of 5′ and/or intronically localised nucleopro-
tein complexes with each other or with the basal transcription
machinery, as in MITF regulation (Watanabe et al., 2002). Future
experiments should test these possibilities.
The endothelin receptor B gene (Ednrb) was the second SOX10
target identiﬁed (Fig. 4C). To elucidate the molecular mechanisms
involved in the regulation of Ednrb expression, the Ednrb locus was
dissected out using a transgenesis strategy. A 78 kb clone was isolated
and its rescue capacity tested in Ednrb null mice (Zhu et al., 2004).
Partial depigmentation and complete intestinal phenotype rescue
observed suggested that this clone contains the necessary information
for expression of Ednrb in ENS progenitors. Further analysis revealed
that a region lying between −1.2 kb and −160 bp from the Ednrb
initiator ATG was sufﬁcient to drive reporter gene expression in the
ENS from E11.5 onwards. Three SOX10 putative binding sites were
identiﬁed within this 1 kb region (see Fig. 4C, S1, S2 and S3) and
SOX10 monomeric binding was observed on all three in vitro. How-
ever, mutagenesis and transgenic analysis revealed that the second
site (S2) is the primary binding site in vivo (Zhu et al., 2004). SOX10
binding sites were subsequently proposed as targets for identifying
potential regulatory mutations in isolated HSCR, but results obtained
so far did not conﬁrm this possibility .
Finally, SOX10 is able to regulate its own expression during ENS
development (Fig. 4A and D, see the next section for details).
Besides these direct SOX10 target genes, SOX10 regulates the
Fig. 4. SOX10 interactome and SOX10 target genes. (A) Schematic diagram of SOX10 interactome during ENS development. Dark blue arrows indicate direct regulation of
Ret, Ednrb and Sox10 by SOX10. Blue connections indicate genetic interactions identiﬁed through large scale or double mutant strategies. (B) Schematic of the Ret gene and
identiﬁed regulatory sequences. Ret coding exons 1 and 2 (black), intronic regions (grey) and regulatory elements (dark blue) are highlighted. Putative SOX (red) or PAX
(blue) binding sites which are essential for Ret regulation in vivo and in vitro are indicated and conservation between mouse and human sequences indicated by asterisks.
(C) Schematic of the Ednrb gene and identiﬁed ENS regulatory sequence. Colour codes are as in (B). (D) Schematic of the Sox10 gene and regulatory sequences essential
during ENS development. Functional SOX binding sites which are required for U1 and U3 regulation in vivo and in vitro are indicated in red and conservation between mouse
and human sequences indicated by asterisks as in (B).
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the gut. Although no direct interaction has been shown, SOX10
thus modulates Phox2b and Mash1 expression (Elworthy et al.,
2005; Kim et al., 2003). Recently, a ChIP-Seq analysis of genes
associated with myelinating peripheral nerve loss of function
identiﬁed a range of new genes regulated by SOX10 (Srinivasan
et al., 2012). ChIP-seq and RNA-seq analyses should increase the
list of the genes regulated by SOX10 in various tissues and in the
ENS in particular in the near future.Sox10/SOX10 gene regulation
Full elucidation of SOX10 function also relies on the identiﬁca-
tion of its regulators. As early as 2003, studies performed in
Xenopus, zebraﬁsh, mouse and chick have suggested that SOX10
expression is under the regulation of several transcription factorsincluding SOX9, Olig2, FoxD3, and Snail, as well as the BMPs, FGF,
Wnt, and Notch signalling pathways (Aoki et al., 2003; Cheung and
Briscoe, 2003; Dutton et al., 2008; Honore et al., 2003; Kim et al.,
2003). The recent characterisation of Sox10/SOX10 regulatory
elements has brought new perspectives.
High sequence conservation surrounding the Sox10 promoter
region (5′ exons 1 through 3) ﬁrst suggested that this region might
contain functional regulatory elements, but these genomic
sequences failed to direct reporter gene expression in most of
the typical Sox10 expression sites in vitro (Antonellis et al., 2008;
Deal et al., 2006). A BAC transgenic analysis was therefore under-
taken. A genomic region of 218 kb ﬂanking the Sox10 locus and
containing the major Sox10 regulatory sequences was deﬁned by
evaluating the ability of a BAC clone to complement NC defects in
Sox10 mutants (Deal et al., 2006). In parallel, several groups
searched for regulatory regions by identifying, in the vicinity of
the mouse or human gene, sequences that exhibited high
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2006, 2008; Betancur et al., 2010; Bondurand et al., 2012; Deal
et al., 2006; Werner et al., 2007; Yokota et al., 2011). Five
sequences located upstream (called U1−5) and three sequences
located downstream (called D6−8) of the SOX10/Sox10 gene were
thus identiﬁed by three different groups (Bondurand et al., 2012;
Werner et al., 2007; Yokota et al., 2011). Nine elements upstream
of Sox10 (called MCS1C-9) were identiﬁed by another group
(Antonellis et al., 2008). MCS2 overlaps with U5, MCS4 with U3,
MCS5 with U2, and MCS7 with U1. Finally, a fourth group
identiﬁed two elements downstream of the chick Sox10 gene
(Betancur et al., 2010); one of them, SoxE2, overlaps with D7.
Interestingly, the conservation of the identiﬁed regions is
restricted to amniotes (Werner et al., 2007), and some of these
sequences are localised up to ∼60 kb upstream of the SOX10 start
codon (Antonellis et al., 2008; Bondurand et al., 2012; Werner
et al., 2007). In zebrasﬁsh, a conserved regulatory sequence
located in intron 1 was identiﬁed (Dutton et al., 2008).
Functional analysis revealed that several of these elements
drive expression in different cell lines as well as in Sox10 expres-
sing cell types and tissues in transgenic models or upon injection
into zebraﬁsh. The regulatory elements have overlapping activ-
ities, but clear spatiotemporal differences were observed. Expres-
sion in the otic vesicle, oligodendrocytes and several NC
derivatives, including dorsal root ganglia, sympathetic ganglia,
cranial ganglia, peripheral nerves, melanocytes, adrenal gland
and ENS, was detected (Antonellis et al., 2008; Dutton et al.,
2008; Werner et al., 2007). Interestingly, some of the identiﬁed
sequences did not show enhancer activity under the experimental
conditions used (Werner et al., 2007). It is possible that these
sequences would show activity in their natural environment or in
combination with the endogenous SOX10/Sox10 gene promoter.
Alternatively, some of the regions might serve as silencers or have
other functions in chromatin organisation. Future experiments
should help test these hypotheses.
In silico binding site prediction and ﬁrst in vitro validation
experiments conﬁrmed that most of these enhancers are under
the regulation of different sets of transcription factors, including
PAX3, AP2α, LEF1, FOXD3, SLUG, SOX9 and SOX10 itself (Antonellis
et al., 2006, 2008; Betancur et al., 2010; Betancur et al., 2011; Deal
et al., 2006; Kuspert et al., 2011; Werner et al., 2007). Deep
characterisation of Sox10E2 revealed that different combinations
of paralogous transcription factors, SOX8, pea3 and cMyb versus
SOX9, Ets1, and cMyb, are required to mediate regulation of this
enhancer in the ear and NC, respectively (Betancur et al., 2011). U2,
by contrast, was found to be dependent on OLIG2 and Nkx6.2 for
correct spatiotemporal expression in oligodendrocytes (Kuspert
et al., 2011). Finally, analysis of U1 and U3 revealed that SOX10
could regulate its own expression, in combination with other
transcription factors important during NC development including
PAX3, FOXD3, AP2 α, EGR2 and SOX2 (Antonellis et al., 2008;
Wahlbuhl et al., 2012). SOX10 bound as a monomer (at least three
sites in U3, S2, S7 and S9 in Fig. 4D) or dimer (one dimeric site in
U3, called S5+6 Fig. 4D and one in U1, called S1+2 in Fig. 4D).
Deletions or mutations in identiﬁed binding sites severely reduced
the enhancer activity in vitro and in transgenic models validating
their importance. Very recently, ChiP-Seq experiments performed
on different cell populations during oligodendrocyte differentia-
tion revealed that BRG1 and OLIG2 co-occupied E-box sequences
on each of the SOX10 enhancers described thus far (Yu et al., 2013).
Data regarding Sox10 gene regulation during ENS development
are emerging. U1 and U3, as well as MCS8 and MCS1C, are able to
drive expression of a reporter gene in enteric progenitor cells in
transgenic mice and zebraﬁsh (Fig. 2D); (Antonellis et al., 2008;
Werner et al., 2007). U1 and U3 are also required to drive BAC
transgene expression in the ENS (Deal et al., 2006). Finally, a 16 kbdeletion encompassing U1 in the Sox10Hry mouse model, which is
characterised by distal intestinal aganglionosis and severe hypo-
pigmentation, conﬁrmed the importance of this regulatory ele-
ment (Antonellis et al., 2006). However, a deletion encompassing
U1 caused dark brown (DB) plumage in chickens, without affecting
the ENS (Gunnarsson et al., 2011). These discrepancies may result
from the additional deletion of MCS8 in the Sox10Hry mouse.
ENS factors involved in the regulation of U1, U3, MCS8 and
MCS1C remain largely unknown. A detailed analysis of U1 revealed
the presence of one SOX dimeric binding site (Fig. 4D; (Antonellis
et al., 2008)). Several SOX binding sites are also present in the U3
sequence (Fig. 2D) and deletion of one or all (3 monomeric and
1 dimeric) severely affected reporter gene expression in NC
derivatives and in the ENS, in particular, suggesting that at least
one of these binding sites is critical for Sox10 expression in some
or all ENS cells (Wahlbuhl et al., 2012). Recently, luciferase gene
reporter experiments revealed that PHOX2B repressed U1 and U3
activity (Nagashimada et al., 2012). Although direct binding was
not evaluated, these results, added to the in vivo analysis, revealed
that Sox10 regulation by PHOX2B is pivotal for the development of
the autonomic ganglia, and the ENS in particular. Following their
identiﬁcation, involvement of each of these regulatory elements in
human pathology was evaluated (see below).Involvement of SOX10 in Human pathology: phenotype
variability and functional consequences of mutations identiﬁed
The identiﬁcation of Sox10 as the gene mutated in the Dommouse
prompted us and others to test its involvement in HSCR and
Waardenburg–Hirschsprung disease (Pingault et al., 1998, 2010). Also
known as Waardenburg syndrome type 4 (WS4), or Waardenburg–
Shah syndrome, Waardenburg–Hirschsprung encompasses clinical
signs of HSCR (intestinal aganglionosis) and Waardenburg syndrome
(pigmentation defects and deafness). The clinical and molecular bases
of HSCR and Waardenburg syndrome have been extensively
described in recent reviews (Amiel et al., 2008; Goldstein et al.,
2013; Obermayr et al., 2012; Pingault et al., 2010) and will therefore
not be detailed here. Concerning SOX10, screening of 15 WS4 cases
led to the identiﬁcation of the ﬁrst 4 heterozygous SOX10 mutations;
two of them being de novo (Pingault et al., 1998). This report also
highlighted the intrafamilial phenotype variability. In addition, bowel
problems but no HSCR was reported in one of the affected patients.
To date, approximately 100 SOX10 mutations have been identiﬁed
(for review see Pingault et al. (2010)). These mutations cause variable
phenotypes that spread over the initial limits of the Waardenburg
syndrome and Hirschsprung disease deﬁnition. In addition to the
WS4 phenotype, neurological variants were identiﬁed (PCWH, Per-
ipheral demyelinating neuropathy–Central dysmyelinating leukody-
strophy–Waardenburg syndrome–Hirschsprung disease) (see for
examples Inoue et al. (2002, 2004)). Interestingly, some of the WS4
or PCWH patients present with chronic intestinal pseudo-obstruction
instead of HSCR (see for examples (Pingault et al., 2002, 2000) and for
review Pingault et al. (2010)). Other phenotypes associated with
SOX10 mutations now include WS2 (depigmentation and deafness
without HSCR), WS2 with peripheral and central demyelination
defects (PCW) and isolated HSCR, showing large variability and
incomplete penetrance of each feature (Bondurand et al., 2007;
Sanchez-Mejias et al., 2010, and for review Pingault et al. (2010)).
Up to now, screening of 229 isolated HSCR cases has led to the
identiﬁcation of only one mutation (Pingault et al., 1998; Sanchez-
Mejias et al., 2010). The latter (c.153−155del) is inherited from the
unaffected mother and is located before the HMG domain, putatively
resulting in a truncated protein without functional motifs (Sanchez-
Mejias et al., 2010). In vitro functional assays revealed abnormal
localisation of the mutant protein in the cytoplasm, loss of
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Haploinsufﬁciency was therefore proposed, but additional phenom-
ena, such as enhanced expression of the wild-type allele in the non-
affected tissues, might explain the distinct phenotype observed.
Involvement of modiﬁer genes was also proposed.
Most of the mutations detected to date are reported in a recent
review (Pingault et al., 2010), and a mutation database for all WS
genes has been developed and is regularly updated in a publicly
accessible website: http://grenada.lumc.nl/LOVD2/WS/. Most of
the SOX10 disease-associated point mutations, regardless of the
phenotype, result in premature termination codons (PTCs). The
presence or absence of a neurological phenotype that characterises
the PCWH or PCW has been hypothesised to be related to the
nonsense-mediated mRNA decay (NMD) process (Inoue et al.,
2004). Although all mutations were reported to have dominant
negative activity in vitro, truncating mutations located in the ﬁrst
coding exons (exons 3 and 4) activate the NMD RNA surveillance
pathway, leading to haploinsufﬁciency and classic WS4 pheno-
types. Truncating mutations located in the last coding exon (exon
5) escape NMD, leading to translation of an abnormal SOX10
protein with a dominant negative activity, resulting in the more
severe PCWH phenotype. A few years ago, we observed that the
length of intestinal aganglionosis may also ﬁt the NMD hypothesis,
as most of the point mutations associated with the long segment
HSCR were located in the ﬁfth exon (Bondurand et al., 2007; Sham
et al., 2001). Accordingly, full deletions of SOX10 were expected to
cause classic forms of WS4 with short segment HSCR as a result of
haploinsufﬁciency. Patients with a SOX10 deletion indeed pre-
sented with short segment HSCR; however, the identiﬁcation of
whole gene deletion in PCWH patients could not be explained by
this hypothesis (Bondurand et al., 2007).
The fact that missense mutations (i.e., escaping NMD) can cause
various phenotypes, ranging from WS2 to PCWH, suggest that
other mechanisms also contribute to the phenotypic variability
observed. The ﬁrst SOX10 missense mutation was identiﬁed in a
patient presenting with a peculiar phenotype, Yemenite deaf blind
hypopigmentation syndrome (YSDBHS mild form, now reclassiﬁed
as WS2 (Bondurand et al., 1999)). Functional analysis of this
mutation suggested that differential tissue-speciﬁc gene regula-
tion could account for the phenotypic differences observed.
Indeed, this mutation abolished DNA binding, while maintaining
transcriptional activation of RET and EDNRB (and therefore proper
enteric development) but not MITF (Bondurand et al., 1999; Lang
and Epstein, 2003; Yokoyama et al., 2006). However, 14 SOX10
missense mutations associated with a variety of phenotypes,
ranging from WS2 to WS4 and PCWH, have since been described
(Barnett et al., 2009; Chaoui et al., 2011; Morin et al., 2008). In vitro
functional analysis conﬁrmed their deleterious effects, but no
correlation between the in vitro results and the phenotypes could
be established (Chaoui et al., 2011). Despite the fact that six of the
mutations maintained complete or partial activity of the MITF
promoter, all patients presented with pigmentation defects. No
correlation between RET and GJB1 activation and ENS or myelina-
tion defects was apparent either (Chaoui et al., 2011). Develop-
ment of additional functional in vivo tests is therefore required to
facilitate genotype–phenotype correlations. The only model cur-
rently proposed is in ovo chick electroporation in the developing
neural tube (Cossais et al., 2010). However, the effect of most of the
mutations on early NC development precludes their analysis on
later developmental processes. Use of an inducible model and/or
long term follow-up of electroporated cells would be of interest.
Alternative models also need to be developed.
Interestingly, half of the missense mutations tested were found
to form speciﬁc accumulations in the nuclei of transfected cells
(Chaoui et al., 2011). Based on 3D modelling, the possibility that
some of these “punctate” mutants disrupt the tertiary structure ofthe HMG domain was considered, but the stability of the mutant
proteins was unaltered. Characterisation of the molecular nature
of this observation will help clarify whether the foci are a cause or
a consequence of mutation-related pathogenicity and provide a
better understanding of the function and mode of action of SOX10
and possibly other SOX factors.
Finally, screening of 13 patients presenting with a classical WS4
phenotype, and 9 patients with a PCWH phenotype, with no
molecular explanation recently led to the ﬁrst characterisation of
a large de novo deletion encompassing 3 SOX10 regulatory
elements (U1, U2 and U3) in a WS4 patient (Bondurand et al.,
2012). We hypothesise that the variations affecting some of the
identiﬁed regulatory sequences could be the cause of other
phenotypes, such as WS2, isolated HSCR or could play a role in
phenotypic variability. This paradigm parallels recent ﬁndings
demonstrating that endophenotypes of campomelic dysplasia
can result from tissue-restricted alterations in SOX9 expression
due to disruption of tissue-speciﬁc, long-distance regulatory
regions (Benko et al., 2009, 2011; Gordon et al., 2009). Screening
for mutations in SOX10 regulatory regions in WS2 revealed
unfruitful (Baral et al., 2012), but the same strategy should help
testing the importance of these regulatory elements in diverse
phenotypes in the near future.
Despite the increasing number of identiﬁed mutations, geno-
type/phenotype correlations are still partly unresolved. One muta-
tion, p.Met112Ile, is associated with WS2 or PCW/PCWH in
unrelated families, opening the possibility that the genetic back-
ground is inﬂuential, as is often suggested for HSCR (Amiel et al.,
2008; Chaoui et al., 2011; Gabriel et al., 2002; McCallion et al.,
2003). Modiﬁer gene identiﬁcation has been hampered by the
small number of patients available so far. As a result, most of the
modiﬁer gene studies have relied on Sox10 mouse models
(Cantrell et al., 2004; Owens et al., 2005; Southard-Smith et al.,
1999a). Variations in penetrance and expressivity of enteric
aganglionosis and pigmentation abnormalities observed in differ-
ent genetic backgrounds suggest that Sox10 mutant mice are good
models for identiﬁcation of modiﬁer genes, which may lead to
recognition of homologous modiﬁers in humans (Kapur et al.,
1996; Puliti et al., 1995; Southard-Smith et al., 1999a).Interactions with other ENS genes: modiﬁer genes
identiﬁcation and double mouse mutant studies
Different approaches have been used to identify SOX10 modi-
ﬁer genes. One strategy was based on N-ethyl–N-nitrosourea
mutagenesis screens and analysis of mutant phenotype on a
SOX10 heterozygote sensitised background. Three modiﬁers that
increase the pigmentation severity, and four that lead to partial
loss or ectopic expression of Sox10, open neural tube, or disorga-
nised Sox10 cell migration, were identiﬁed on chromosomes 3,
4 and 13, and 6, 9, 10, and 11, respectively (Buac et al., 2008;
Matera et al., 2008). In two cases, mutations within ErbB3 and Gli3
were identiﬁed. The role of both factors and their signalling
pathway in the developing ENS (Chalazonitis et al., 2011; Fu
et al., 2004) suggests that it could be interesting to analyse ENS
development in Sox10;ErbB3 and Sox10;Gli3 double mutants in the
future.
Other studies have relied on the use of the Dom mouse model.
To systematically identify genes that modulate Sox10-dependent
aganglionosis, Southard-Smith and colleagues performed a single
nucleotide polymorphism-based genome scan in Sox10Dom/+ F1
intercross progeny (Owens et al., 2005). They identiﬁed ﬁve
putative modifying loci for Sox10 on chromosomes 3, 5, 8, 11 and
14 with distinct effects on enteric phenotype penetrance and
severity. Fine mapping on chromosome 5, coupled with
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involvement of Phox2b conﬁrmed (Fig. 4A, (Owens et al., 2005)).
The modiﬁer gene on chromosome 14 is Ednrb (see below, Fig. 4A),
but the modiﬁer genes at the other three loci on chromosomes 3,
8, and 11 have yet to be determined.
Southard-Smith and colleagues also tested for speciﬁc associa-
tion between genes in the endothelin signalling pathway (Ednrb,
Edn3 and Ece1) and the severity of aganglionosis in extended
pedigree of B6C3FeLe.SoxDom mice (Cantrell et al., 2004). Single
locus association identiﬁed interaction between Sox10 and Ednrb.
Additional analysis of F2 intercrosses conﬁrmed a highly signiﬁ-
cant effect of Ednrb alleles on the Dom phenotype and crosses
between Ednrb and Sox10 mutants corroborated this genetic
interaction (Cantrell et al., 2004). Double mutant analysis per-
formed by one of our groups also revealed a genetic interaction
between Sox10 and Edn3 (Fig. 4A; (Stanchina et al., 2006)). Double
heterozygotes and double mutants exhibited an increase in ENS
phenotype penetrance and severity. No clear proliferation, NCC
survival or differentiation defects were observed upon gut coloni-
sation. Instead, the more severe ENS defect was suggested to result
from increased cell death of vagal NCC prior to their invasion of
the foregut. Use of various Ednrb mutants helped deﬁne the
requirement for a minimum EDNRB activity level (30−50%) for
normal ENS development (Stanchina et al., 2006). At the molecular
level, the interaction between SOX10 and the endothelin-3/EDNRB
pathways is partially explained by transcriptional regulation of
Ednrb by SOX10 (Zhu et al., 2004). However, the vagal NC
anomalies observed in E10 Sox10;Ednrb double mutants suggest
a possible cooperativity between SOX10 and the endothelin-3/
EDNRB signalling pathways earlier during development. We sug-
gest that this “earlier” interaction could be explained by another
regulatory loop between endothelin-3 and SOX10 (Stanchina et al.,
2006). Future experiments should address this issue.
Two locus complementation approaches led to the identiﬁca-
tion of four additional Sox10 modiﬁers during ENS development:
Sox8, Itgb1, L1cam and Zeb2 (Fig. 4A; (Maka et al., 2005; Stanchina
et al., 2010; Wallace et al., 2010; Watanabe et al., 2013). The latter
two genes were previously shown to affect enteric development
both in mouse and human. Mutations of the human L1CAM gene
result in CRASH syndrome (corpus callosum agenesis, mental
retardation, hydrocephalus and, in some cases, HSCR;
(Nakakimura et al., 2008; Okamoto et al., 1997)). ZEB2 mutations
are responsible for most of the Mowat–Wilson syndrome cases
(mental retardation, craniofacial abnormalities, and HSCR in
approximately 50% of the cases; (Cacheux et al., 2001; Dastot-Le
Moal et al., 2007; Wakamatsu et al., 2001)). Double mouse mutant
studies revealed that loss or haploinsufﬁciency of L1cam in
conjunction with heterozygous loss of Sox10 signiﬁcantly
increased the incidence of intestinal aganglionosis compared to
Sox10 mutation alone, although it did not increase the severity of
the phenotype (Wallace et al., 2010). Increased cell death of vagal
NCC prior to invasion of the foregut may be at the origin of the
defects observed and the use of an N2A cell line revealed that
L1cam expression was up-regulated upon Sox10 induction. Direct
binding of SOX10 to L1cam regulatory sequences remains to be
tested. By contrast, haploinsufﬁciency of Zeb2 in conjunction with
heterozygous loss of Sox10 increased both the incidence and
severity of intestinal aganglionosis of Sox10 mutants (Stanchina
et al., 2010). In this case, no defects were observed before E11.5
and the more severe ENS defects were proposed to result from
decreased proliferation of ENS progenitors and increased neuronal
differentiation (accelerated terminal differentiation). The under-
lying molecular mechanism is not known but may be mediated by
modulating BMP expression (Stanchina et al., 2010). Loss or
haploinsufﬁciency of Sox8 signiﬁcantly increased both the inci-
dence and severity of intestinal aganglionosis in Sox10heterozygous mutants as well (Maka et al., 2005). While prolifera-
tion and neuronal differentiation of ENCC were normal in the gut,
apoptosis was dramatically increased in vagal NCC prior to gut
entry. Glial differentiation was also affected in double mutants,
suggesting that Sox8 and Sox10 are jointly required for mainte-
nance of the vagal NCC pool and for glial differentiation within the
gut. Finally, one of our teams recently showed that Sox10 hetero-
zygous ENC progenitors depleted in β1-integrins exhibit more
severe migratory defects during midgut colonisation than single
mutants from E11.5 onwards, strongly suggesting that SOX10 acts
on enteric NCC adhesion and migration through β1-integrins
regulation (Watanabe et al., 2013).Perspectives
Developmental anomalies observed in various animal models
and in human disorders associated with SOX10 mutations revealed
the essential function of this transcription factor during NC and
ENS formation in particular. Generation of various animal models,
screening for modiﬁer genes, and characterisation of regulatory
elements, as well as identiﬁcation of SOX10 target genes have all
contributed to our understanding of SOX10 function in these NC-
derived cells. Although a number of questions remain, some of
them are raised during the course of this review.
What are the molecular bases for the variable enteric pheno-
types of patients with SOX10 mutations? How does SOX10 control
various cellular processes during ENS development? Better char-
acterisation of the genetic and transcriptional regulatory network
during ENS development, i.e., increasing the list of SOX10 target
genes and identiﬁcation of speciﬁc ENS partners, is now crucial to
answer the latter question. Although difﬁcult to conduct, these
studies should beneﬁt from newly available hypomorph or condi-
tional mutants (Finzsch et al., 2010; Schreiner et al., 2007), as well
as from ChIP-Seq and RNA-Seq strategies. Interestingly, glial
differentiation relies on Sox10 regulation by BRG1 (oligodendro-
cytes) followed by BRG1 recruitment to some SOX10 targets
(Schwann cells) (Weider et al., 2012; Yu et al., 2013). The ability
to recruit chromatin remodelling complexes to speciﬁc regions of
the genome of a differentiating Schwann cell truly makes SOX10
an architectural transcription factor, thus giving a whole meaning
to this term that was originally ascribed to SOX proteins because of
their ability to bend DNA (Weider et al., 2012). Whether such
interactions take place in the control of SOX10 target genes during
various phases of ENS development needs to be examined.
We believe ChIP-Seq and RNA-Seq strategies will not only
provide opportunities for enhanced understanding of the function
and mode of action of SOX10 and possibly other SOX factors, but
could also lead to the identiﬁcation of new genes involved in
isolated or syndromic HSCR.
The mechanisms of SOX10/Sox10 gene regulation control and
the identities of the regulators in enteric development are also
highly important. There is no doubt that careful in vitro and in vivo
analysis of SOX10 ENS-expressed enhancers will lead to the
characterisation of new factors involved in Sox10 regulation.
Methylation is also an important regulator of Sox10 expression
(Strobl-Mazzulla et al., 2010). The histone demethylase JmjD2A is
responsible for demethylation of H3K9me3 at −0.5 kb from the
transcription start site of the Sox10 gene, which in turn dere-
presses expression of Sox10 transcripts in emerging NC. Whether
similar mechanisms take place during ENS development should be
tested.
Finally, post-translational modiﬁcations and SUMOylation, in
particular, have been proposed as one of the mechanisms by which
transcription factors that play context-dependent roles are regu-
lated such that they direct appropriate cellular and developmental
N. Bondurand, M.H. Sham / Developmental Biology 382 (2013) 330–343340outcomes. SUMOylation of SOX-E transcription factors profoundly
affect their function, inhibiting their NC inducing activity and
promoting ear formation (Taylor and Labonne, 2005). SUMOyla-
tion converts SOX-E factors to transcriptional repressors, displa-
cing co-activators such as CREB-binding protein/p300 while
recruiting the Grg4 corepressor (Girard and Goossens, 2006; Lee
et al., 2012). The role of SUMOylation during ENS development is
unknown.
In conclusion, we propose that further understanding of SOX10
function will beneﬁt from genomic and cell biological studies that
integrate the cell-intrinsic molecular mechanisms and the inter-
actions of the enteric NCCs with the niche environment.Acknowledgements
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